RA Capital Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RA Capital Management's NVAX Position: Q2 2022 in Review
RA Capital Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 692,794 shares — an estimated $51M sold.
RA Capital Management first reported a position in NVAX in Q2 2013 and held it in 18 quarters. The position peaked at $544M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- RA Capital Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- RA Capital Management sold 692,794 Novavax shares in Q2 2022, an estimated $51M.
- RA Capital Management first reported a position in Novavax in Q2 2013 and held it in 18 quarters.
- RA Capital Management's Novavax position peaked at $544M in Q1 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on RA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.